fda bpc 157 category 2 compounding panel votes to place popular peptide BPC-157 on list BREAKING: The FDA just reversed
BREAKING: The FDA just reversed theIR 2023 peptide ban. 12 peptides were just pulled from the Category 2 restricted list: 1. BPC 157 2. Thymosin beta 4 fragment (TB 500) 3. Epitalon 4. GHK Cu (injectable) FDA Advisers Vote to Ease Restrictions on BPC 157, TB 500, and Other Novel Peptides Glitchwire Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy Peptides like BPC 157 and TB 500 are blowing up online for injury recovery, but theyre not FDA approved and theyre in a legal gray area. The end of July, an FDA advisory committee meets to weigh in
Pay in 4 interest-free payments of $7.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

